|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net of allowance of $9 and $9 | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Margin deposits and other prepaid expense | ||||||||||||||||||||
| Restricted cash, current | ||||||||||||||||||||
| Derivative assets, current | ||||||||||||||||||||
| Current assets held for sale | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Restricted cash, net of current portion | ||||||||||||||||||||
| Investments in unconsolidated subsidiaries | ||||||||||||||||||||
| Derivative Asset, Noncurrent | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES & STOCKHOLDER’S EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Debt, current portion | ||||||||||||||||||||
| Derivative Liability, Current | ||||||||||||||||||||
| Current liabilitites held for sale | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Debt, net of current portion | ||||||||||||||||||||
| Long-term derivative liabilities | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholder’s equity: | ||||||||||||||||||||
| Preferred stock, $0.001 par value per share; authorized 100,000,000 shares, none issued and outstanding at December 31, 2017 and 2016 | ||||||||||||||||||||
| Common stock, $0.001 par value per share; authorized 5,000 shares, 105.2 shares issued and outstanding | ||||||||||||||||||||
| Treasury stock, at cost, nil and 1,161,800 shares, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total Calpine stockholder’s equity | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total stockholder’s equity | ||||||||||||||||||||
| Total liabilities and stockholder’s equity | ||||||||||||||||||||
Loading...
